Because SREBF1 is known to be induced in the NAFLD/NASH liver and be involved in its formation (Chen et al, 2004; Ferre & Foufelle, 2010), its intronic miR-33b is also expected to be induced and exert some function in this condition, but it remains unclear. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.